he conventional treatment for brain metastases is whole brain radiotherapy (WBRT). 1 But there has been a gradual move to managing limited brain metastases with stereotactic radiosurgery (SRS), 2 and delaying or avoiding WBRT because of its effects on cognition and quality of life. Data on contemporary SRS practice for managing brain metastases in Australia are, however, very limited. 3 We performed a population-based linkage study, analysing data from the Victorian Cancer Registry and the Victorian Radiotherapy Minimum Data Set (VRMDS). We included all patients with solid tumours (ICD-10 codes C00-C80), but excluding primary central nervous systems malignancies (ICD-10 codes C69-72), who received brain radiotherapy in Victoria between 1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.